Specifically, in vitro, pretreatment with MLA (50 μM) or MEM (50 μM) significantly attenuated the survival rates of HBMECs and reduced the expression of inflammatory cytokines (such as IL-6 and TNF-α) after E. coli infection. Here, IL6 is linked to escherichia coli infection.